Opendata, web and dolomites

BADGER

calScreener® – an innovative device for Bacterial Analysis and Diagnostics through Growth and Energy-release in Real-time

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "BADGER" data sheet

The following table provides information about the project.

Coordinator
SYMCEL AB 

Organization address
address: DOMNARVSGATAN 4
city: SPANGA
postcode: 163 53
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-07-01   to  2016-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYMCEL AB SE (SPANGA) coordinator 50˙000.00

Map

 Project objective

The overall objective of the project is to commercialize calScreener™ - the first multi-channel calorimetry system for Antimicrobial Susceptibility Testing (AST). The clinical importance of AST tests is increasing in line with the growing concerns over antimicrobial-resistant infections. De-spite the vast amount of research that has been done to improve AST testing standards globally, there are several clinical areas where the testing cannot be performed due to the lack of proper monitoring/assay technologies. An example is Biofilm Infections where no diagnostic standards exist. Through the project, SymCel will propose calScreener™ , a calorimetry based diagnostic tool, as a novel and viable approach to target unmet diagnostic needs. The key need of clinicians dealing with bacterial infections is an accurate and quick diagnostic test that will help to determine if and what type of antibiotic should be used in the patient. The test should be objective and actionable, i.e. providing information at the choice of therapy. calScreener™ will meet those needs by delivering detailed and correct information about the type of bacteria involved in the infection enabling quick choice of individualized patient therapy. In the Phase 1 project, SymCel will develop a business plan that will guide the upcoming validation and exploitation efforts. By validating and commercializing calScreener™ as a diagnostic tool, the BADGER project will make an important contribution to fighting anti-microbial resistance in Europe, and increase the level of Antibiotic Stewardship.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BADGER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BADGER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More